Suppr超能文献

SILAC 激酶筛选鉴定潜在的 MASTL 底物。

SILAC kinase screen identifies potential MASTL substrates.

机构信息

ANZAC Research Institute, Concord Hospital, Concord, NSW, 2139, Australia.

Children's Medical Research Institute, The University of Sydney, Westmead, Australia.

出版信息

Sci Rep. 2022 Jun 22;12(1):10568. doi: 10.1038/s41598-022-14933-0.

Abstract

Microtubule-associated serine/threonine kinase-like (MASTL) has emerged as a critical regulator of mitosis and as a potential oncogene in a variety of cancer types. To date, Arpp-19/ENSA are the only known substrates of MASTL. However, with the roles of MASTL expanding and increased interest in development of MASTL inhibitors, it has become critical to determine if there are additional substrates and what the optimal consensus motif for MASTL is. Here we utilized a whole cell lysate in vitro kinase screen combined with stable isotope labelling of amino acids in cell culture (SILAC) to identify potential substrates and the residue preference of MASTL. Using the related AGC kinase family members AKT1/2, the kinase screen identified several known and new substrates highly enriched for the validated consensus motif of AKT. Applying this method to MASTL identified 59 phospho-sites on 67 proteins that increased in the presence of active MASTL. Subsequent in vitro kinase assays suggested that MASTL may phosphorylate hnRNPM, YB1 and TUBA1C under certain in vitro conditions. Taken together, these data suggest that MASTL may phosphorylate several additional substrates, providing insight into the ever-increasing biological functions and roles MASTL plays in driving cancer progression and therapy resistance.

摘要

微管相关丝氨酸/苏氨酸激酶样(MASTL)已成为有丝分裂的关键调节因子,也是多种癌症类型中的潜在癌基因。迄今为止,Arpp-19/ENSA 是 MASTL 的唯一已知底物。然而,随着 MASTL 作用的不断扩展以及对 MASTL 抑制剂开发的兴趣日益浓厚,确定是否存在其他底物以及 MASTL 的最佳共识基序变得至关重要。在这里,我们利用全细胞裂解物体外激酶筛选结合稳定同位素标记的细胞培养氨基酸(SILAC)来鉴定潜在的底物和 MASTL 的残基偏好。使用相关的 AGC 激酶家族成员 AKT1/2,激酶筛选鉴定出了几种已知和新的底物,它们高度富集 AKT 的验证共识基序。将该方法应用于 MASTL 鉴定出 67 种蛋白质上的 59 个磷酸化位点,在活性 MASTL 存在的情况下这些磷酸化位点增加。随后的体外激酶测定表明,在某些体外条件下,MASTL 可能会磷酸化 hnRNPM、YB1 和 TUBA1C。总之,这些数据表明 MASTL 可能会磷酸化几个其他底物,为不断增加的生物学功能和 MASTL 在推动癌症进展和治疗耐药性方面的作用提供了深入了解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/070d/9217955/448fe52250fe/41598_2022_14933_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验